Federated Hermes Inc. Increases Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Federated Hermes Inc. increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 766.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,045 shares of the company’s stock after buying an additional 1,809 shares during the quarter. Federated Hermes Inc.’s holdings in Henry Schein were worth $140,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Farther Finance Advisors LLC grew its stake in Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after purchasing an additional 1,898 shares during the last quarter. State of Alaska Department of Revenue grew its stake in Henry Schein by 2.8% during the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock valued at $1,000,000 after purchasing an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock valued at $941,000 after purchasing an additional 678 shares during the last quarter. GAMMA Investing LLC grew its stake in Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock valued at $270,000 after purchasing an additional 1,081 shares during the last quarter. Finally, Wellington Management Group LLP grew its stake in Henry Schein by 12.6% during the 4th quarter. Wellington Management Group LLP now owns 6,902 shares of the company’s stock valued at $478,000 after purchasing an additional 775 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Baird R W downgraded Henry Schein from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 14th. Robert W. Baird reiterated a “neutral” rating and set a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. UBS Group lowered their target price on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 6th. Leerink Partners set a $75.00 target price on Henry Schein in a research note on Monday, July 14th. Finally, Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 30th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $75.58.

Henry Schein Stock Performance

NASDAQ HSIC opened at $65.94 on Monday. The stock has a market capitalization of $8.00 billion, a price-to-earnings ratio of 21.27, a PEG ratio of 2.17 and a beta of 0.81. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The stock has a 50-day moving average of $71.07 and a 200 day moving average of $71.06.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The business’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.23 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.